Townsend Letter for Doctors and Patients, April 1st, 2002
Scientists have found that creating an antibody-producing vaccine that will prevent HIV from entering cells, is very difficult. Some researchers are investigating partial-protection vaccines that keep HIV levels in check by stimulating killer T-cells. Although killer T-cells cannot eradicate HIV from the body, their action is expected to prevent or delay the onset of symptoms. In his article for The Wall Street Journal, Mark Schoofs explains that infected cells display epitopes, fragments of viral proteins, on the cellular surface. When a killer cell finds the one eptiope it is programmed to...
HighBeam Research, Free Preview: 'HIV Vaccine. (Shorts).'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
